MedPage Today on MSN
Evolocumab Reduced First CV Events in Patients Without Prior MI or Stroke
N EW ORLEANS -- Adding the PCSK9 inhibitor evolocumab (Repatha) to stable lipid-lowering therapy reduced major adverse ...
It’s the first study to show a PCSK9 inhibitor can reduce major events in high-risk patients who haven’t yet had one.
Q3 2025 Earnings Call Transcript November 6, 2025 AMN Healthcare Services, Inc. beats earnings expectations. Reported EPS is ...
More than 250 residents filled the Ste. Rose Health Centre on October 18 to celebrate a remarkable milestone — four decades ...
As physician shortages deepen across the U.S., health systems are increasingly turning to locum tenens providers to maintain patient access and revenue. CHG Healthcare's newly released 2025 State of ...
PHOENIX (AZFamily) — The next generation of healthcare professionals can soon be trained right here in the Valley. Arizona State University’s newly named John Shufeldt School of Medicine and Medical ...
Amid the federal government shutdown, the Centers for Medicare & Medicaid Services (CMS) on Wednesday appeared to announce a pause on all Medicare payments to doctors, but then quickly backed off. An ...
When Dr. Banu Symington first moved to Rock Springs, Wyo., 30 years ago, she appreciated its empty desert landscapes and small-town respect for physicians like herself. Fast-forward to today. Some of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results